FMC Corporation has secured a strategic minority investment of approximately $400 million from Belgium-based industrial conglomerate Tessenderlo Group, a transaction that significantly bolsters the agricultural sciences company's financial position and marks the conclusion of its strategic review process.
Under the definitive agreement, Tessenderlo Group will acquire a roughly 20 percent ownership stake in FMC through an equity investment priced at $13.30 per share. The deal aligns with Tessenderlo's long-term strategy of building an agricultural platform through cornerstone investments in companies with strong growth prospects and differentiated technologies.
For FMC, the investment represents a pivotal step in its efforts to improve financial flexibility and accelerate the execution of its operational and strategic priorities. The company intends to use the proceeds to further reduce debt, enabling it to achieve its target of approximately $1 billion in debt repayment.
The transaction also brings an end to the strategic alternatives review initiated earlier this year, with FMC opting to continue operating as an independent company while advancing its innovation pipeline and strengthening its competitive position in the global crop protection market.
Over the past several months, FMC has undertaken a series of initiatives aimed at enhancing liquidity, unlocking capital and sharpening its strategic focus. These measures include amending its revolving credit facility to obtain covenant relief, raising $1.2 billion through a secured high-yield bond offering, and agreeing to sell its India commercial business for $252 million.
The company has also entered into a strategic supply and licensing agreement with Corteva that includes an initial prepayment of $200 million, alongside a framework agreement for the sale and leaseback of its Newark, Delaware, property valued at approximately $114 million.
Collectively, these actions have significantly strengthened FMC's balance sheet and provided additional flexibility to invest in research and development, commercialize new technologies and pursue long-term growth opportunities.
The investment underscores confidence in FMC's pipeline of proprietary molecules and next-generation crop protection solutions, which are expected to play an increasingly important role as the agricultural sector seeks innovative technologies to improve productivity and sustainability.
The transaction remains subject to customary closing conditions, including the receipt of necessary regulatory approvals. Upon completion, the partnership is expected to provide FMC with enhanced financial resilience and a stronger foundation to pursue its strategic ambitions in the global agricultural sciences industry.
